Drug profile · INN
drotrecogin alfa (activated)
XIGRIS
drotrecogin alfa (activated) (XIGRIS) is a coagulation factor v inhibitor.
EMA: withdrawn Blood and blood forming organs (B01) B01AD10
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — drotrecogin alfa (activated)
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
drotrecogin alfa (activated) (XIGRIS) is a coagulation factor v inhibitor.
Key facts
INN drotrecogin alfa (activated)
Brand XIGRIS
Mechanism Coagulation factor V inhibitor
Target Coagulation factor V
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AD10
Mechanism of action
Coagulation factor V inhibitor
Primary target: Coagulation factor V
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is drotrecogin alfa (activated)?
drotrecogin alfa (activated) (XIGRIS) is a coagulation factor v inhibitor.
What is the brand name for drotrecogin alfa (activated)?
XIGRIS is a marketed brand name for drotrecogin alfa (activated). Check FDA Drugs@FDA for the current US label holder and prescribing information.